Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer

Urology

Volumn 10, Issue 6, 1977, Pages 556-561

  Byar, David ^a   Blackard, Clyde ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PYRIDOXINE; THIOTEPA; TRYPTOPHAN;

BLADDER CANCER; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMPARISON; DRUG THERAPY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PAPILLOMATOSIS; RANDOMIZED CONTROLLED TRIAL; THERAPY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; CLINICAL TRIALS; DRUG EVALUATION; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; PLACEBOS; PYRIDOXINE; THIOTEPA; URINARY BLADDER NEOPLASMS;

EID: 0017657105     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/0090-4295(77)90101-7     Document Type: Article

References (24)

1. Current clinical problems regarding bladder tumors
2. Benign papilloma or papillary carcinoma of the bladder?
3. Mouse bladder carcinogenicity of certain tryptophan metabolites and other aromatic nitrogen compounds suspended in cholesterol
4. Studies on the etiology of carcinoma of the urinary bladder
5. The metabolism of tryptophan in patients with bladder cancer
6. Relationship between tryptophan metabolism and heterotopic recurrences of human urinary bladder tumors
7. Thio-TEPA in the treatment of tumors of the bladder
8. Bladder carcinoma treated by direct instillation of thio-TEPA
9. The randomized clinical trial: a prerequisite for rational therapy
10. EORTC randomized trial for the adjuvant therapy of TI bladder carcinoma
11. Maximum utilization of the life table method in analyzing survival
12. Evaluation of survival data and two new rank order statistics arising in its consideration
13. Statistical methods for survival time studies
14. Abnormal tryptophan metabolism in a family with a history of bladder cancer
15. Studies on tryptophan metabolism in patients with bladder cancer
16. The metabolism of tryptophan in patients with bladder cancer and other urological diseases
17. Tryptophan metabolism in patients with bladder cancer: geographical differences
18. Anergy and tryptophan metabolism in bladder cancer
19. Chemotherapy for bladder cancer
20. Intravesical infusion with cystosine arabinoside (kiloside) for tumors of the bladder
21. Antineoplastic effects of intracystic administration of cancer chemotherapeutic agents
22. Mitomycin C bladder instillation therapy for bladder tumors
23. Preliminary evaluation of VM26, a new epipodophyllotoxin derivative in the treatment of urogenital tumours